Improvement in academic behaviors after successful treatment of convergence insufficiency
- PMID: 22080400
- PMCID: PMC3261761
- DOI: 10.1097/OPX.0b013e318238ffc3
Improvement in academic behaviors after successful treatment of convergence insufficiency
Abstract
Purpose: To determine whether treatment of symptomatic convergence insufficiency (CI) has an effect on Academic Behavior Survey (ABS) scores.
Methods: The ABS is a six-item survey developed by the Convergence Insufficiency Treatment Trial Group that quantifies the frequency of adverse school behaviors and parental concern about school performance on an ordinal scale from 0 (never) to 4 (always) with total scores ranging from 0 to 24. The ABS was administered at baseline and after 12 weeks of treatment to the parents of 218 children aged 9 to 17 years with symptomatic CI, who were enrolled in the Convergence Insufficiency Treatment Trial and randomized into (1) home-based pencil push-ups; (2) home-based computer vergence/accommodative therapy and pencil push-ups; (3) office-based vergence/accommodative therapy with home reinforcement; and (4) office-based placebo therapy with home reinforcement. Participants were classified as successful (n = 42), improved (n = 60), or non-responder (n = 116) at the completion of 12 weeks of treatment using a composite measure of the symptom score, nearpoint of convergence, and positive fusional vergence. Analysis of covariance methods were used to compare the mean change in ABS between response to treatment groups while controlling for the ABS score at baseline.
Results: The mean ABS score for the entire group at baseline was 12.85 (SD = 6.3). The mean ABS score decreased (improved) in those categorized as successful, improved, and non-responder by 4.0, 2.9, and 1.3 points, respectively. The improvement in the ABS score was significantly related to treatment outcome (p < 0.0001), with the ABS score being significantly lower (better) for children who were successful or improved after treatment as compared to children who were non-responders (p = 0.002 and 0.043, respectively).
Conclusions: A successful or improved outcome after CI treatment was associated with a reduction in the frequency of adverse academic behaviors and parental concern associated with reading and school work as reported by parents.
Figures
References
-
- Borsting E, Rouse MW, Deland PN, Hovett S, Kimura D, Park M, Stephens B. Association of symptoms and convergence and accommodative insufficiency in school-age children. Optometry. 2003;74:25–34. - PubMed
-
- Rouse MW, Borsting E, Hyman L, Hussein M, Cotter SA, Flynn M, Scheiman M, Gallaway M, De Land PN, The Convergence Insufficiency and Reading Study (CIRS) Group Frequency of convergence insufficiency among fifth and sixth graders. Optom Vis Sci. 1999;76:643–9. - PubMed
-
- Letourneau JE, Lapierre N, Lamont A. The relationship between convergence insufficiency and school achievement. Am J Optom Physiol Opt. 1979;56:18–22. - PubMed
-
- Letourneau J, Ducic S. Prevalence of convergence insufficiency among elementary school children. Can J Optom. 1988;50:194–7.
-
- Borsting EJ, Rouse MW, Mitchell GL, Scheiman M, Cotter SA, Cooper J, Kulp MT, London R, Convergence Insufficiency Treatment Trial (CITT) Investigator Group Validity and reliability of the revised convergence insufficiency symptom survey in children aged 9 to 18 years. Optom Vis Sci. 2003;80:832–8. - PubMed
Publication types
MeSH terms
Grants and funding
- EY014710/EY/NEI NIH HHS/United States
- U10 EY014709/EY/NEI NIH HHS/United States
- EY014659/EY/NEI NIH HHS/United States
- U10 EY014715/EY/NEI NIH HHS/United States
- EY014709/EY/NEI NIH HHS/United States
- U10 EY014710/EY/NEI NIH HHS/United States
- EY014713/EY/NEI NIH HHS/United States
- U10 EY014659/EY/NEI NIH HHS/United States
- EY014715/EY/NEI NIH HHS/United States
- U10 EY014712/EY/NEI NIH HHS/United States
- EY014712/EY/NEI NIH HHS/United States
- U10 EY014676/EY/NEI NIH HHS/United States
- U10 EY014706/EY/NEI NIH HHS/United States
- U10 EY014713/EY/NEI NIH HHS/United States
- EY014676/EY/NEI NIH HHS/United States
- EY014706/EY/NEI NIH HHS/United States
- EY014716/EY/NEI NIH HHS/United States
- U10 EY014716/EY/NEI NIH HHS/United States
LinkOut - more resources
Full Text Sources
Medical
